Lung Cancer (With Focus On Elderly)

Edward B. Garon, M.D., MS Associate Clinical Professor, Director Of Thoracic Oncology Program, David Geffen School Of Medicine At UCLA, Director Of Signal Transduction And Therapeutics, Jonsson Comprehensive Cancer Center At UCLA, Discusses Lung Cancer (With Focus On Elderly). Dr. Garon Elaborates On The ECOG 4599 Trial Looking At Paclitaxel & Carboplatin + Bevacizumab In First Line NSCLC & The Efficacy Of Nivolumab Monotherapy. He Also Discusses The SWOG 9504 Trial Looking At Docetaxel After Concurrent Chemoradiotherapy And How It Did Much Better Then Historical Controls. This Was All discussed At MOASC Oncology Summit On Feb 23, 2019.

For More Info Visit: https://moasc.org…